logo

For the Inventor, By the Inventor

Fukuoka, Japan

Tohru Nakao

This inventor holds 10 USPTO granted patents. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1976-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tohru Nakao. Retrieved from https://idiyas.com/inventor/tohru-nakao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 99(Granted Patents)


Location History:

  • Yoshitomi, JA (1976)
  • Fukuoka, JA (1976)
  • Nakatsu, JP (1992)
  • Oita, JP (1992 - 1994)
  • Fukuoka, JP (1995 - 1997)

Company Filing History:

goldMedal10 out of 198 
 
Yoshitomi Pharmaceutical Industries, Ltd.
 patents

Years Active: 1976-1997

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5691330 - Condensed thiophene compound and pharmaceutical use thereof (1997-11-25),
2. 5597918 - Fused pyridazine compound (1997-01-28),
3. 5532240 - Condensed thiophene compound and pharmaceutical use thereof (1996-07-02),
4. 5466691 - Thiophene compound (1995-11-14),
5. 5329016 - Intermediates for the preparation of pharmaceutical thiophene compounds (1994-07-12),
6. 5175162 - Thiophene compounds and their pharmaceutical uses (1992-12-29),
7. 5153194 - Thienocycloheptapyridazine compounds and their pharmaceutical use (1992-10-06),
8. 5141930 - Fused thiophene compounds and uses thereof (1992-08-25),
9. 3978071 - Substituted phenylalkanoic acids and derivatives (1976-08-31),
10. 3954776 - 1-[Methylated piperidino(and pyrrolidin-1-yl)]-3-(substituted (1976-05-04),

Title: Tohru Nakao: Innovator in Pharmaceutical Compounds

Introduction

Tohru Nakao is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as therapeutic agents. With a total of 10 patents to his name, Nakao's work has the potential to impact the treatment of various mental health conditions.

Latest Patents

Nakao's latest patents include a condensed thiophene compound and a fused pyridazine compound. The condensed thiophene compound is represented by a specific general formula and is noted for its pharmaceutical use as an antipsychotic drug. This compound is designed to have a reduced extrapyramidal side effect, making it a valuable option for patients. The fused pyridazine compound, on the other hand, is characterized by its ability to act as an anxiolytic agent. It selectively targets anxiety while minimizing side effects such as muscle relaxation and sedation.

Career Highlights

Tohru Nakao is currently associated with Yoshitomi Pharmaceutical Industries, Ltd., where he continues to innovate in the pharmaceutical sector. His work is recognized for its potential to improve patient outcomes through the development of new therapeutic agents.

Collaborations

Nakao has collaborated with notable colleagues, including Yasuto Morimoto and Hiroshi Tanaka. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Tohru Nakao's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor in the industry. His work not only showcases his expertise but also emphasizes the importance of continued research in developing effective treatments for mental health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…